FindTrial
Sign In

Epidural analgesia versus Remifentanil PCA during labour - OER-study

Epidural analgesia versus Remifentanil PCA during labour - OER-study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-005424-33-NL
Enrollment
Unknown
Registered
2007-10-10
Start date
2008-02-06
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To compare Remifentanil PCA with epidural anesthesia among healthy nulligravidia during labor.

Interventions

Trade Name: Ultiva Pharmaceutical Form: Powder and solvent for solution for infusion Trade Name: Bupivacaine Pharmaceutical Form: Solution for injection

Sponsors

Sint Lucas Andreas
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: nulligravida without serious systemic disease in partu, less than 6cm dilatation healthy in labour Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: American Society of Anesthesiologists (ASA) >2 (pre)eclampsia HELLP syndrome serious diabetic gravidarum infection placenta praevia psychiatric disorder

Design outcomes

Primary

MeasureTime frame
Main Objective: Patients' satisfaction;Secondary Objective: Outcome of the infant, APGAR. Vacuum or forceps deliveries;Primary end point(s): satisfaction—

Countries

Netherlands

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026